webinar register page

Webinar banner
Human milk oligosaccharides: Prebiotics in a class of their own?
Human milk oligosaccharides are non-digestible carbohydrates and are the third most abundant component in human milk after lactose and fat. More than 200 different varieties have currently being identified in human milk, of which 2’-fucosyllactose is the most prevalent. Human milk oligosaccharides have been described to play an important role in the development of the intestinal microbiota and the immune system of infants, which may influence health later in life [Gibson et al, 2017]. In the past few years the number of scientific in-vitro and in-vivo studies on the postulated health benefits of human milk oligosaccharides has increased enormously. In this webinar, we will cover an overview of what human milk oligosaccharides are, how they can play a role in infant health and the current scientific state of the art on postulated beneficial effects.

Oct 19, 2022 10:00 AM in Eastern Time (US and Canada)

* Required information
Loading

Speakers

Ardythe Morrow PhD
Professor of Pediatrics @Cincinnati Children’s Hospital Medical Center, University of Cincinnati College of Medicine
Karen Scott PhD
Senior Research Fellow in the Microbial Ecology Group @Rowett Institute, University of Aberdeen
Dr. Scott is Karen is responsible for leading a research team investigating the (molecular) mechanisms by which key members of the gut microbiota utilise specific dietary components such as prebiotics (including human milk oligosaccharides) and fibre. She is also interested in the development of the gut microbiota throughout life, from birth.
Margriet Schoterman PhD
Senior Clinical Trial Coordinator and Nutrition Credibility Roadmap Manager @FrieslandCampina
Margriet Schoterman has 25 years of experience working in various roles in a global R&D environment of food industry and business. With a background in Nutrition Science, she initiated and coordinated several multidisciplinary research projects with external partners and experts worldwide, among which projects in the field of prebiotics. Margriet is an active member of ISAPP, (co-)author of several scientific publications in international journals and co-inventor of patent applications.